US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

19.14

+0.08000.42%

Post-market: 19.140.00000.00%16:10 EDT

Volume:1.22M

Turnover:23.34M

Market Cap:1.22B

PE:-8.17

High:19.33

Open:18.82

Low:18.59

Close:19.06

52wk High:28.00

52wk Low:6.91

Shares:63.60M

Float Shares:47.12M

Volume Ratio:1.27

T/O Rate:2.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3433

EPS(LYR):-3.1931

ROE:-89.18%

ROA:-33.59%

PB:0.42

PE(LYR):-5.99

Loading ...

Overview Company News Filings

Jade Biosciences: Buy Rating Reiterated on Strong Cash Runway, JADE101 Differentiation, and Unchanged $24 Price Target

Wedbush Raises Price Target on Jade Biosciences to $34 From $24, Maintains Outperform Rating

MT Newswires Live

Analyst Reiterates Buy on Jade Biosciences as JADE101 Data and Multi-Asset Pipeline Catalysts Approach

Jade Biosciences files $600M mixed securities shelf

BRIEF-Jade Biosciences Inc - May Offer And Sell Up To $600 Million Of Securities - SEC Filing

Jade Biosciences Inc - Registration Statement Covers Resale of up to 39,542,339 Shares of Common Stock by the Selling Stockholders - SEC Filing

THOMSON REUTERS

Jade Biosciences Inc - May Offer and Sell up to $600 Mln of Securities - SEC Filing

THOMSON REUTERS

Jade Biosciences Q1 EPS $(0.57) Misses $(0.51) Estimate

Benzinga Earnings

Jade Biosciences Q1 net loss widens to $40.4 million; R&D expenses rise to $36.1 million

BRIEF-Jade Biosciences, Inc Q1 Cash & Investments USD 311.3 Million

Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update

Jade Biosciences Reshapes Clinical Leadership As Valuation Debate Persists

Simply Wall St.

A Look At Jade Biosciences (JBIO) Valuation After Its Recent Share Price Surge

Simply Wall St.

Jade Biosciences Is Maintained at Buy by HC Wainwright & Co.

Jade Biosciences price target raised to $45 from $35 at H.C. Wainwright

Jade Biosciences, Inc. : H.c. Wainwright Raises Target Price to $45 From $35

THOMSON REUTERS

Jade Biosciences grants CMO Conner stock options for 500,000 shares at $25.38

Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Analysts Conflicted on These Healthcare Names: Jade Biosciences (JBIO), Elevance Health (ELV) and Regeneron (REGN)

Jade Biosciences appoints Edward Conner as chief medical officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/JBIO/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"JBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":19.14,"timestamp":1789070400000,"preClose":19.06,"halted":0,"volume":1224853,"hourTrading":{"tag":"盘后","latestPrice":19.14,"preClose":19.14,"latestTime":"16:10 EDT","volume":1448,"amount":27714.72,"timestamp":1789071007677,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0041972717733474215,"floatShares":47122000,"shares":63597387,"eps":-2.343303,"marketStatus":"Post-Mkt","change":0.08,"latestTime":"09-10 17:44:36 EDT","open":18.82,"high":19.33,"low":18.59,"amount":23342349,"amplitude":0.038825,"askPrice":21.94,"askSize":500,"bidPrice":17.33,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.343303,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":19.06,"preHourTrading":{"tag":"盘前","latestPrice":18.85,"preClose":19.06,"latestTime":"09:29 EDT","volume":642,"amount":12054.91746,"timestamp":1789046999999,"change":-0.21,"changeRate":-0.011018,"amplitude":0.103882},"postHourTrading":{"tag":"盘后","latestPrice":19.14,"preClose":19.14,"latestTime":"16:10 EDT","volume":1448,"amount":27714.72,"timestamp":1789071007677,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.269006,"impliedVol":1.1523,"impliedVolPercentile":0.8287},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","floatShares":47122000,"roa":"-33.59%","roe":"-89.18%","lyrEps":-3.193116,"volumeRatio":1.269006,"shares":63597387,"dividePrice":0,"high":19.33,"amplitude":0.038825,"preClose":19.06,"low":18.59,"week52Low":6.91,"pbRate":"0.42","week52High":28,"institutionHeld":0,"latestPrice":19.14,"committee":-0.666667,"eps":-2.343303,"divideRate":0,"volume":1224853,"delay":0,"ttmEps":-2.343303,"open":18.82,"prevYearClose":15.43,"prevWeekClose":19.9,"prevMonthClose":21.36,"prevQuarterClose":22.22,"fiveDayClose":21.4,"twentyDayClose":23.21,"sixtyDayClose":16.1,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.15429122468659595},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"JBIO","fiscalQuarterEnding":"2026/06","expectedEps":-0.66,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.76},{"market":"US","date":"2026-05-07","symbol":"JBIO","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2026-03-06","symbol":"JBIO","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772773200000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-11-13","symbol":"JBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2025-08-13","symbol":"JBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JBIO\",market:\"US\",,,undefined,":[{"executeDate":"2025-04-29","recordDate":"2025-04-25","paymentDate":"2025-04-28","value":2.4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5455,"buy":0.4545,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5455,"analysts":11,"updateTime":1781496000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JBIO","date":"2026-09-09","current":-8.167958,"percent":0.271084,"low":-10.392766,"twenty":-8.849201,"median":-6.332426,"eighty":-2.849663,"high":-2.319279,"avg":-5.904189,"sd":2.681284,"marketCap":1236969177},"quantilePoints":[{"date":"2025-05-16","current":-2.4743,"twenty":-2.881556,"median":-2.868851,"eighty":-2.514424,"marketCap":232480279},{"date":"2025-05-23","current":-2.511409,"twenty":-2.870857,"median":-2.517932,"eighty":-2.47965,"marketCap":235966978},{"date":"2025-05-30","current":-2.432499,"twenty":-2.695315,"median":-2.507901,"eighty":-2.466944,"marketCap":228552715},{"date":"2025-06-06","current":-2.363881,"twenty":-2.548988,"median":-2.487393,"eighty":-2.464507,"marketCap":222105530},{"date":"2025-06-13","current":-2.381035,"twenty":-2.548988,"median":-2.48419,"eighty":-2.428382,"marketCap":223717326},{"date":"2025-06-20","current":-3.228464,"twenty":-2.618978,"median":-2.48419,"eighty":-2.41603,"marketCap":303340063},{"date":"2025-06-27","current":-3.17357,"twenty":-2.886906,"median":-2.487393,"eighty":-2.426323,"marketCap":298182315},{"date":"2025-07-03","current":-3.822008,"twenty":-3.217485,"median":-2.511409,"eighty":-2.437181,"marketCap":359108215},{"date":"2025-07-11","current":-3.609293,"twenty":-3.553713,"median":-2.554094,"eighty":-2.45809,"marketCap":339121941},{"date":"2025-07-18","current":-3.262773,"twenty":-3.420594,"median":-2.844205,"eighty":-2.467494,"marketCap":306563656},{"date":"2025-07-25","current":-2.857929,"twenty":-3.391775,"median":-2.873866,"eighty":-2.470924,"marketCap":268525263},{"date":"2025-08-01","current":-2.466808,"twenty":-3.382854,"median":-2.844205,"eighty":-2.467494,"marketCap":231776307},{"date":"2025-08-08","current":-2.511409,"twenty":-3.347859,"median":-2.705254,"eighty":-2.467494,"marketCap":235966978},{"date":"2025-08-15","current":-2.350869,"twenty":-3.260028,"median":-2.645214,"eighty":-2.467494,"marketCap":220882962},{"date":"2025-08-22","current":-2.56269,"twenty":-3.244933,"median":-2.581542,"eighty":-2.467494,"marketCap":240785267},{"date":"2025-08-29","current":-2.805764,"twenty":-3.217485,"median":-2.645214,"eighty":-2.470924,"marketCap":263623978},{"date":"2025-09-05","current":-2.70159,"twenty":-3.17357,"median":-2.64603,"eighty":-2.473669,"marketCap":253835959},{"date":"2025-09-12","current":-2.694645,"twenty":-3.152985,"median":-2.64603,"eighty":-2.4743,"marketCap":253183424},{"date":"2025-09-19","current":-2.677282,"twenty":-3.087798,"median":-2.64603,"eighty":-2.473669,"marketCap":251552088},{"date":"2025-09-26","current":-2.798819,"twenty":-3.080936,"median":-2.64603,"eighty":-2.4743,"marketCap":262971443},{"date":"2025-10-03","current":-2.892576,"twenty":-3.080936,"median":-2.67381,"eighty":-2.479351,"marketCap":271780660},{"date":"2025-10-10","current":-3.264131,"twenty":-3.152985,"median":-2.690514,"eighty":-2.480987,"marketCap":306691262},{"date":"2025-10-17","current":-3.397822,"twenty":-3.16343,"median":-2.70159,"eighty":-2.487393,"marketCap":319252553},{"date":"2025-10-24","current":-3.448173,"twenty":-3.228464,"median":-2.743259,"eighty":-2.487393,"marketCap":323983428},{"date":"2025-10-31","current":-3.420393,"twenty":-3.264131,"median":-2.760622,"eighty":-2.487393,"marketCap":321373290},{"date":"2025-11-07","current":-3.10787,"twenty":-3.295384,"median":-2.802291,"eighty":-2.501116,"marketCap":292009233},{"date":"2025-11-14","current":-3.361361,"twenty":-3.350943,"median":-2.840774,"eighty":-2.504393,"marketCap":315826746},{"date":"2025-11-21","current":-5.620897,"twenty":-3.393147,"median":-2.85789,"eighty":-2.511409,"marketCap":528128273},{"date":"2025-11-28","current":-6.276995,"twenty":-3.403031,"median":-2.873866,"eighty":-2.511409,"marketCap":589773908},{"date":"2025-12-05","current":-6.071353,"twenty":-3.439839,"median":-2.892576,"eighty":-2.514154,"marketCap":570452142},{"date":"2025-12-12","current":-7.266038,"twenty":-3.474564,"median":-2.963052,"eighty":-2.522532,"marketCap":682702402},{"date":"2025-12-19","current":-8.108193,"twenty":-3.595569,"median":-2.993278,"eighty":-2.527742,"marketCap":761829634},{"date":"2025-12-26","current":-8.093505,"twenty":-3.607234,"median":-3.022611,"eighty":-2.532681,"marketCap":760449508},{"date":"2026-01-02","current":-7.554917,"twenty":-3.822008,"median":-3.080936,"eighty":-2.536797,"marketCap":709844883},{"date":"2026-01-09","current":-6.487534,"twenty":-5.801079,"median":-3.116551,"eighty":-2.545612,"marketCap":609555716},{"date":"2026-01-16","current":-7.197491,"twenty":-6.02239,"median":-3.152985,"eighty":-2.555745,"marketCap":676261813},{"date":"2026-01-23","current":-8.333421,"twenty":-6.159485,"median":-3.153012,"eighty":-2.557134,"marketCap":782991569},{"date":"2026-01-30","current":-7.530436,"twenty":-6.394505,"median":-3.1685,"eighty":-2.564099,"marketCap":707544672},{"date":"2026-02-06","current":-7.045707,"twenty":-6.577625,"median":-3.177319,"eighty":-2.571103,"marketCap":662000509},{"date":"2026-02-13","current":-7.251349,"twenty":-6.621691,"median":-3.225463,"eighty":-2.577189,"marketCap":681322276},{"date":"2026-02-20","current":-7.124047,"twenty":-6.808238,"median":-3.251382,"eighty":-2.579625,"marketCap":669361182},{"date":"2026-02-27","current":-7.128943,"twenty":-6.986952,"median":-3.264131,"eighty":-2.583458,"marketCap":669821224},{"date":"2026-03-06","current":-6.795998,"twenty":-6.986952,"median":-3.314482,"eighty":-2.597415,"marketCap":638538365},{"date":"2026-03-13","current":-5.364757,"twenty":-6.933093,"median":-3.361361,"eighty":-2.602624,"marketCap":683523737},{"date":"2026-03-20","current":-5.449912,"twenty":-6.913508,"median":-3.389716,"eighty":-2.60436,"marketCap":694373320},{"date":"2026-03-27","current":-5.399593,"twenty":-6.874338,"median":-3.399558,"eighty":-2.630404,"marketCap":687962203},{"date":"2026-04-02","current":-6.200823,"twenty":-6.843002,"median":-3.403031,"eighty":-2.640126,"marketCap":790046917},{"date":"2026-04-10","current":-7.056243,"twenty":-6.843002,"median":-3.432606,"eighty":-2.644683,"marketCap":899035912},{"date":"2026-04-17","current":-8.46904,"twenty":-6.943865,"median":-3.47248,"eighty":-2.645867,"marketCap":1079040359},{"date":"2026-04-24","current":-9.757975,"twenty":-7.080959,"median":-3.477689,"eighty":-2.64603,"marketCap":1243263595},{"date":"2026-05-01","current":-9.451524,"twenty":-7.125026,"median":-3.585277,"eighty":-2.656356,"marketCap":1204218641},{"date":"2026-05-08","current":-9.381799,"twenty":-7.197491,"median":-3.600715,"eighty":-2.670835,"marketCap":1195335061},{"date":"2026-05-15","current":-9.189592,"twenty":-7.279748,"median":-3.609293,"eighty":-2.676588,"marketCap":1191053783},{"date":"2026-05-22","current":-8.934431,"twenty":-7.436993,"median":-3.822008,"eighty":-2.684564,"marketCap":1157982667},{"date":"2026-05-29","current":-7.936639,"twenty":-7.480494,"median":-5.132517,"eighty":-2.691341,"marketCap":1028659795},{"date":"2026-06-05","current":-6.756045,"twenty":-7.480494,"median":-5.23899,"eighty":-2.696728,"marketCap":875644182},{"date":"2026-06-12","current":-7.36451,"twenty":-7.480494,"median":-5.370563,"eighty":-2.700201,"marketCap":954506790},{"date":"2026-06-18","current":-7.726324,"twenty":-7.487348,"median":-5.393787,"eighty":-2.710604,"marketCap":1001401091},{"date":"2026-06-26","current":-9.988804,"twenty":-7.591639,"median":-5.407335,"eighty":-2.731778,"marketCap":1294638873},{"date":"2026-07-02","current":-9.988804,"twenty":-7.673406,"median":-5.426688,"eighty":-2.743259,"marketCap":1294638873},{"date":"2026-07-10","current":-10.295658,"twenty":-7.795377,"median":-5.444106,"eighty":-2.744648,"marketCap":1334409990},{"date":"2026-07-17","current":-9.379675,"twenty":-7.921008,"median":-5.585386,"eighty":-2.752288,"marketCap":1215690240},{"date":"2026-07-24","current":-8.985802,"twenty":-8.046029,"median":-5.655171,"eighty":-2.766178,"marketCap":1164640747},{"date":"2026-07-31","current":-9.159838,"twenty":-8.108193,"median":-5.875502,"eighty":-2.788402,"marketCap":1187197500},{"date":"2026-08-07","current":-10.18574,"twenty":-8.267967,"median":-5.948946,"eighty":-2.798819,"marketCap":1320163620},{"date":"2026-08-14","current":-9.881583,"twenty":-8.338317,"median":-6.086042,"eighty":-2.805764,"marketCap":1514253784},{"date":"2026-08-21","current":-8.810836,"twenty":-8.64582,"median":-6.164381,"eighty":-2.819654,"marketCap":1350172526},{"date":"2026-08-28","current":-8.835737,"twenty":-8.844495,"median":-6.229853,"eighty":-2.840774,"marketCap":1353988369},{"date":"2026-09-04","current":-8.238111,"twenty":-8.852338,"median":-6.276995,"eighty":-2.844205,"marketCap":1262408131},{"date":"2026-09-09","current":-8.072104,"twenty":-8.849201,"median":-6.332426,"eighty":-2.849663,"marketCap":1236969177}],"updateTime":1789076676343},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JBIO\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633445293","title":"Jade Biosciences: Buy Rating Reiterated on Strong Cash Runway, JADE101 Differentiation, and Unchanged $24 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2633445293","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633445293?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:55","pubTimestamp":1778248525,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Jade Biosciences today and set a price target of $24.00. Rami Katkhuda has given h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/jade-biosciences-buy-rating-reiterated-on-strong-cash-runway-jade101-differentiation-and-unchanged-24-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/jade-biosciences-buy-rating-reiterated-on-strong-cash-runway-jade101-differentiation-and-unchanged-24-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633245661","title":"Wedbush Raises Price Target on Jade Biosciences to $34 From $24, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2633245661","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633245661?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:22","pubTimestamp":1778242942,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) has an average rating of Buy and mean price target of $24.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633431524","title":"Analyst Reiterates Buy on Jade Biosciences as JADE101 Data and Multi-Asset Pipeline Catalysts Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=2633431524","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633431524?lang=en_us&edition=fundamental","pubTime":"2026-05-08 17:36","pubTimestamp":1778232985,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has maintained their bullish stance on JBIO stock, giving a Buy rating today. Matt Phipps has given his Buy ratin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-jade-biosciences-as-jade101-data-and-multi-asset-pipeline-catalysts-approach-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-jade-biosciences-as-jade101-data-and-multi-asset-pipeline-catalysts-approach-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633058151","title":"Jade Biosciences files $600M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2633058151","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633058151?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:32","pubTimestamp":1778193132,"startTime":"0","endTime":"0","summary":"17:17 EDT Jade Biosciences (JBIO) files $600M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-files-600m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-files-600m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633103496","title":"BRIEF-Jade Biosciences Inc - May Offer And Sell Up To $600 Million Of Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633103496","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633103496?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:27","pubTimestamp":1778192858,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences Inc - May Offer And Sell Up To $600 Million Of Securities - SEC FilingMay 7  - SEC Filing: JADE BIOSCIENCES INC - MAY OFFER AND SELL UP TO $600 MILLION OF SECURITIES - SEC FILINGJADE BIOSCIENCES INC - MAY OFFER AND SELL UP TO $200 MILLION COMMON STOCK UNDER SALES AGREEMENT WITH JEFFERIES - SEC FILINGSource text: [ID:n0001193125-26-212422]Further company coverage: JBIO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633170901","title":"Jade Biosciences Inc - Registration Statement Covers Resale of up to 39,542,339 Shares of Common Stock  by the Selling Stockholders  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633170901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633170901?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:21","pubTimestamp":1778188898,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1MN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633170548","title":"Jade Biosciences Inc - May Offer and Sell up to $600 Mln of Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633170548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633170548?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:15","pubTimestamp":1778188553,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633174738","title":"Jade Biosciences Q1 EPS $(0.57) Misses $(0.51) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633174738","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633174738?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:35","pubTimestamp":1778186138,"startTime":"0","endTime":"0","summary":"Jade Biosciences (NASDAQ:JBIO) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.51) by 11.76 percent. This is a 95.29 percent increase over losses of $(12.10) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52392153/jade-biosciences-q1-eps-0-57-misses-0-51-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Jade Biosciences Q1 EPS $(0.57) Misses $(0.51) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633637174","title":"Jade Biosciences Q1 net loss widens to $40.4 million; R&D expenses rise to $36.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633637174","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633637174?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:29","pubTimestamp":1778185782,"startTime":"0","endTime":"0","summary":"Jade Biosciences posted a Q1 net loss of $40.4 million, compared with a $38.2 million loss a year earlier.R&D expense climbed to $36.1 million from $20 million, while G&A costs rose to $7.4 million from $3.4 million.Cash, cash equivalents, investments totaled $311.3 million as of March 31, with runway expected into first-half 2028.Phase 2 trial of lead IgA nephropathy candidate JADE101 expected to start in Q2, with interim data expected in 2027; interim biomarker-rich Phase 1 data set for an oral presentation at the European Renal Association Congress.Phase 1 study of JADE201 in rheumatoid arthritis expected to begin in Q2 with interim data expected in 2027, while JADE301 first-in-human trial remains on track for first-half 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLbq1Hkw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4588","LU2210150020.SGD","NDAQ","IE00BN0W2V16.EUR","LU0314104364.USD","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014021.USD","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BN0W2W23.USD","LU2095319765.USD","IE00B3QW5Z07.USD","JBIO","IE00BN0W2T93.GBP","BK4539","BK4139","BK4112","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633179547","title":"BRIEF-Jade Biosciences, Inc Q1 Cash & Investments USD 311.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633179547","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633179547?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184357,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences, Inc Q1 Cash & Investments USD 311.3 Million\n\n\nMay 07 (Reuters) - Jade Biosciences, Inc Q1 net income USD -40.4 million vs. IBES estimate USD -32.5 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLXA86001:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633726311","title":"Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633726311","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633726311?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184300,"startTime":"0","endTime":"0","summary":"Interim biomarker-rich Phase 1 data for JADE101 to be featured in an oral session at the 63rd European Renal Association CongressPhase 2 trial of JADE101 in IgA nephropathy patients expected to begin ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3290531/0/en/Jade-Biosciences-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623219","title":"Jade Biosciences Reshapes Clinical Leadership As Valuation Debate Persists","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632623219?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:49","pubTimestamp":1777672186,"startTime":"0","endTime":"0","summary":"Jade Biosciences (NasdaqCM: JBIO) appointed Edward R. Conner, M.D. as Chief Medical Officer.\nThe company elevated Andrew King, M.D., Ph.D. to President, Research & Development.\nThese leadership changes focus on clinical development, regulatory strategy, and R&D continuity for Jade's autoimmune pipeline.\n\nJade Biosciences, listed on NasdaqCM under the ticker JBIO, is focused on developing therapies for autoimmune conditions, an area that continues to attract capital and partnerships across...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/jade-biosciences-reshapes-clinical-leadership-as-valuation-d","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/jade-biosciences-reshapes-clinical-leadership-as-valuation-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630394343","title":"A Look At Jade Biosciences (JBIO) Valuation After Its Recent Share Price Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2630394343","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630394343?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:07","pubTimestamp":1777324054,"startTime":"0","endTime":"0","summary":"What Jade Biosciences’ Recent Move Means For Investors\n\nJade Biosciences (JBIO) has caught investor attention after a sharp share price move over the past month, prompting a closer look at how its current fundamentals and recent trading performance line up.\n\nSee our latest analysis for Jade Biosciences.\n\nAt a share price of US$24.98, Jade Biosciences has seen momentum build, with a 7 day share price return of 6.3%, a 30 day share price return of 86.6% and a year to date share price return of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/a-look-at-jade-biosciences-jbio-valuation-after-its-recent-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/a-look-at-jade-biosciences-jbio-valuation-after-its-recent-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630396620","title":"Jade Biosciences Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2630396620","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630396620?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:00","pubTimestamp":1777291200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 27, 2026 08:00 ET (12:00 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630367635","title":"Jade Biosciences price target raised to $45 from $35 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2630367635","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630367635?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:16","pubTimestamp":1777284993,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Jade Biosciences (JBIO) to $45 from $35 and keeps a Buy rating on the shares. The company is set ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-price-target-raised-to-45-from-35-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-price-target-raised-to-45-from-35-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630234362","title":"Jade Biosciences, Inc. : H.c. Wainwright Raises Target Price to $45 From $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2630234362","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630234362?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:11","pubTimestamp":1777284683,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nAZN4SSX2S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629833396","title":"Jade Biosciences grants CMO Conner stock options for 500,000 shares at $25.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2629833396","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629833396?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:04","pubTimestamp":1776942288,"startTime":"0","endTime":"0","summary":"Jade Biosciences granted Edward R. Conner non-qualified stock options for 500,000 shares, effective April 22, 2026, tied to his appointment as chief medical officer.Options carry an exercise price of $25.38 per share.Vesting runs over four years, with 25% vesting at one year.Remaining shares vest in 36 equal monthly installments, subject to continued employment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDLbVtPvk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU2095319765.USD","SG9999014021.USD","IE00BKPKM429.USD","LU2210150020.SGD","BK4588","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4539","SG9999014005.SGD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","JBIO","BK4112","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629293838","title":"Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629293838","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629293838?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:00","pubTimestamp":1776942003,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nTUA2LJPFW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629884102","title":"Analysts Conflicted on These Healthcare Names: Jade Biosciences (JBIO), Elevance Health (ELV) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629884102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629884102?lang=en_us&edition=fundamental","pubTime":"2026-04-23 17:41","pubTimestamp":1776937299,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Jade Biosciences (JBIO), Elevance Health (ELV) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-jade-biosciences-jbio-elevance-health-elv-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-jade-biosciences-jbio-elevance-health-elv-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","LU2592432038.USD","LU0225283273.USD","LU2362540622.SGD","LU0345770993.USD","LU2430703095.HKD","LU0433182093.SGD","LU2362541513.USD","SG9999004303.SGD","LU0345770308.USD","BK4137","LU0320765992.SGD","JBIO","LU0251131958.USD","LU0985489474.SGD","SG9999011175.SGD","LU0234570918.USD","LU2089984988.USD","LU0557290698.USD","LU2108987350.USD","LU0048573561.USD","LU2505996509.AUD","LU0266013472.USD","LU1548497426.USD","XBI","LABU","LU0957791311.USD","LU0061474960.USD","LU0251142724.SGD","BK4585","LU0823434740.USD","LU1057294990.SGD","HCSG","LU1506573853.SGD","ELV","LU0068578508.USD","LU1201861249.SGD","REGN","LU0320765489.SGD","LU1280957306.USD","LU2106854487.HKD","LU2362541273.HKD","XLV","LU2430703251.USD","LU0130517989.USD","BK4581","LU0878866978.SGD","LU2237957902.USD","LU0128526141.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629045747","title":"Jade Biosciences appoints Edward Conner as chief medical officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629045747","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629045747?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:54","pubTimestamp":1776858868,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) announced the appointment of Edward Conner as chief medical officer, effective immediately. Conner joins Jade from Ardelyx ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-appoints-edward-conner-as-chief-medical-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-appoints-edward-conner-as-chief-medical-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":118,"code":"91000000","status":"200"}]}}